Literature DB >> 6416569

Acquired immunodeficiency syndrome, hepatitis, and haemophilia.

P Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6416569      PMCID： PMC1549879          DOI： 10.1136/bmj.287.6407.1737

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  7 in total

1.  'Contaminated' plasma: no automatic recall.

Authors:  C Marwick
Journal:  JAMA       Date:  1983-09-02       Impact factor: 56.272

2.  Abnormalities of the spleen and liver in patients with hemophilia.

Authors:  W H Meyer; J Levin; P M Ness; W R Bell; K H Douglass; E E Camargo; W H Zinkham
Journal:  Am J Hematol       Date:  1983-05       Impact factor: 10.047

3.  Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests.

Authors:  G C White; K D Zeitler; H R Lesesne; C W McMillan; M S Warren; H R Roberts; P M Blatt
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

4.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

5.  1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.

Authors:  P M Mannucci; Z M Ruggeri; F I Pareti; A Capitanio
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

6.  Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom.

Authors:  C R Rizza; R J Spooner
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

7.  Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

Authors:  H R Gralnick; M E Rick
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245
  7 in total
  1 in total

1.  Abnormal B cell response to T cell-independent polyclonal B cell activators in haemophilia A.

Authors:  J Kekow; H Plendl; W L Gross
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.